OXCARBAZEPINA 300 MG COM REV CT BL AL PLAS TRANS X 30

Apresentação · Câmara de Regulação do Mercado de Medicamentos (CMED), Secretaria Executiva exercida pela Agência Nacional de Vigilância Sanitária (ANVISA) · Brasil

  • Número de registro 1832600620039
  • GGREM 525067602115111
  • Código de barras 7896422511902

O que a fonte publica

Detentor do registro
SANOFI MEDLEY FARMACÊUTICA LTDA.
Princípios ativos
OXCARBAZEPINA
Embalagem
300 MG COM REV CT BL AL PLAS TRANS X 30
Tipo de produto
Genérico
Classe terapêutica
N3A - ANTIEPILÉPTICOS

Nomes pelos quais este registro é encontrado

Dados completos da fonte
br:cmed:presentations:525067602115111
{
  "name": "OXCARBAZEPINA 300 MG COM REV CT BL AL PLAS TRANS X 30",
  "holder": "SANOFI MEDLEY FARMACÊUTICA LTDA.",
  "stripe": null,
  "barcodes": [
    "7896422511902"
  ],
  "confaz87": false,
  "currency": "BRL",
  "marketed": null,
  "ggremCode": "525067602115111",
  "useDomain": "unknown",
  "capApplies": null,
  "icmsExempt": false,
  "holderTaxId": "10.588.595/0010-92",
  "priceRegime": "Regulado",
  "productName": "OXCARBAZEPINA",
  "productType": "Genérico",
  "hospitalOnly": false,
  "presentation": "300 MG COM REV CT BL AL PLAS TRANS X 30",
  "sourceStatus": null,
  "supplyRegime": null,
  "factoryPrices": {
    "icms-0": "32.33",
    "icms-12": "36.74",
    "icms-17": "38.95",
    "icms-18": "39.43",
    "icms-19": "39.91",
    "icms-20": "40.41",
    "icms-21": "40.92",
    "icms-22": "41.45",
    "icms-23": "41.99",
    "icms-17.5": "39.19",
    "icms-19.5": "40.16",
    "icms-20.5": "40.67",
    "icms-22.5": "41.72",
    "icms-12-alc": "36.30",
    "icms-17-alc": "38.48",
    "icms-18-alc": "38.95",
    "icms-19-alc": "39.43",
    "icms-20-alc": "39.93",
    "icms-21-alc": "40.43",
    "icms-22-alc": "40.95",
    "icms-23-alc": "41.48",
    "withoutTaxes": "31.94",
    "icms-17.5-alc": "38.72",
    "icms-19.5-alc": "39.68",
    "icms-20.5-alc": "40.18",
    "icms-22.5-alc": "41.22"
  },
  "pisCofinsList": "Positiva",
  "substanceText": "OXCARBAZEPINA",
  "targetSpecies": [],
  "consumerPrices": {
    "icms-0": "44.56",
    "icms-12": "50.64",
    "icms-17": "53.69",
    "icms-18": "54.35",
    "icms-19": "55.01",
    "icms-20": "55.70",
    "icms-21": "56.40",
    "icms-22": "57.13",
    "icms-23": "57.88",
    "icms-17.5": "54.02",
    "icms-19.5": "55.36",
    "icms-20.5": "56.06",
    "icms-22.5": "57.51",
    "icms-12-alc": "50.18",
    "icms-17-alc": "53.20",
    "icms-18-alc": "53.85",
    "icms-19-alc": "54.51",
    "icms-20-alc": "55.20",
    "icms-21-alc": "55.89",
    "icms-22-alc": "56.61",
    "icms-23-alc": "57.34",
    "withoutTaxes": "44.16",
    "icms-17.5-alc": "53.53",
    "icms-19.5-alc": "54.86",
    "icms-20.5-alc": "55.55",
    "icms-22.5-alc": "56.98"
  },
  "invalidBarcodes": [],
  "activeSubstances": [
    "OXCARBAZEPINA"
  ],
  "therapeuticClass": "N3A - ANTIEPILÉPTICOS",
  "commercialisation": {
    "year": 2025,
    "marketed": true
  },
  "priceAnalysisNote": null,
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "br.anvisa.cmed-prices"
  },
  "patientEligibility": "not-assessed",
  "registrationNumber": "1832600620039",
  "targetSpeciesStatus": "not-reported",
  "administrativeStatus": "unknown",
  "prescriptionCategory": "unknown",
  "prescriptionRequired": null,
  "therapeuticClassCode": "N3A",
  "commercialDestination": null,
  "registrationNumberFlag": null
}

Leia este registro a partir do seu próprio software

O mesmo registro, com todos os campos e sua procedência, está a uma requisição de distância. A chave de API é gratuita e funciona imediatamente.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=br" \
  --data-urlencode "sourceId=br.anvisa.cmed-prices" \
  --data-urlencode "id=br:cmed:presentations:525067602115111"